BOLOGNESI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 7.561
NA - Nord America 7.413
EU - Europa 4.902
AF - Africa 476
SA - Sud America 405
Continente sconosciuto - Info sul continente non disponibili 350
OC - Oceania 13
Totale 21.120
Nazione #
US - Stati Uniti d'America 7.234
VN - Vietnam 2.064
SG - Singapore 2.052
CN - Cina 1.753
IT - Italia 1.320
GB - Regno Unito 936
HK - Hong Kong 655
DE - Germania 534
SE - Svezia 450
FR - Francia 289
BR - Brasile 276
UA - Ucraina 266
IN - India 260
RU - Federazione Russa 233
CI - Costa d'Avorio 193
NL - Olanda 187
IE - Irlanda 169
FI - Finlandia 141
ZA - Sudafrica 140
KR - Corea 137
JP - Giappone 121
BD - Bangladesh 114
CA - Canada 108
BG - Bulgaria 66
EE - Estonia 64
PH - Filippine 53
ID - Indonesia 49
AR - Argentina 48
TH - Thailandia 48
JO - Giordania 45
BE - Belgio 43
ES - Italia 40
TG - Togo 34
IQ - Iraq 32
SC - Seychelles 32
TR - Turchia 29
TW - Taiwan 29
AT - Austria 28
PK - Pakistan 27
CH - Svizzera 26
MX - Messico 25
PL - Polonia 25
IR - Iran 22
GR - Grecia 19
EC - Ecuador 18
MY - Malesia 17
NG - Nigeria 17
CL - Cile 16
CO - Colombia 16
JM - Giamaica 16
SA - Arabia Saudita 13
DZ - Algeria 12
PY - Paraguay 12
LY - Libia 11
UZ - Uzbekistan 11
AU - Australia 9
RO - Romania 9
EG - Egitto 8
LT - Lituania 8
PT - Portogallo 8
CR - Costa Rica 7
ET - Etiopia 7
VE - Venezuela 7
DK - Danimarca 6
PE - Perù 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
KZ - Kazakistan 5
RS - Serbia 5
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
MA - Marocco 4
NO - Norvegia 4
TN - Tunisia 4
UY - Uruguay 4
BW - Botswana 3
LK - Sri Lanka 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GU - Guam 2
KE - Kenya 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BS - Bahamas 1
Totale 20.750
Città #
Singapore 1.422
Southend 748
Ashburn 694
Hong Kong 619
Santa Clara 574
Ho Chi Minh City 529
Fairfield 510
Chandler 508
Hanoi 451
Bologna 411
San Jose 379
Council Bluffs 284
Hefei 276
Beijing 259
Woodbridge 253
Houston 250
Wilmington 235
Ann Arbor 214
Seattle 210
Princeton 203
Jacksonville 194
Abidjan 193
Cambridge 185
Boardman 184
Dublin 169
Dong Ket 158
Los Angeles 128
Seoul 110
Helsinki 109
Lauterbourg 100
Tokyo 100
Nanjing 91
Milan 88
Westminster 81
Padova 79
Turin 79
Berlin 77
New York 74
Sofia 65
Buffalo 64
Johannesburg 64
Haiphong 61
Da Nang 59
Jinan 59
Saint Petersburg 54
São Paulo 49
Dallas 47
Amman 45
Frankfurt am Main 45
Brussels 43
Falkenstein 43
Shanghai 42
Guangzhou 41
Redondo Beach 41
Shenyang 41
Mülheim 39
Medford 37
Hebei 36
San Diego 35
Lomé 34
Biên Hòa 32
Nanchang 32
Phoenix 32
Redmond 32
Changsha 31
Lappeenranta 31
London 31
Rome 31
Toronto 30
Tianjin 27
Zhengzhou 27
Chicago 26
Orem 26
Thái Nguyên 26
Bangkok 25
Bengaluru 25
Jakarta 23
Des Moines 22
Hangzhou 22
Can Tho 21
Naples 21
Redwood City 21
Ha Long 20
Forlì 19
Hyderabad 19
Mahé 19
Montreal 19
Bern 18
Quận Bình Thạnh 18
Taiyuan 18
Hải Dương 17
Warsaw 17
Abeokuta 16
Dearborn 16
Kunming 16
Modena 16
Taizhou 16
Wuhan 16
Brooklyn 15
Kuala Lumpur 15
Totale 13.176
Nome #
Ricin: An ancient story for a timeless plant toxin 327
Journal of Biological Regulators and Homeostatic Agents 317
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma 284
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 251
Survival and death of intestinal cells infected by Chlamydia trachomatis 241
Membrane lipidome reorganization correlates with the fate of neuroblastoma cells supplemented with fatty acids. 237
The 1.4.ANG. structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. 235
Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress 227
Ribosome-inactivating proteins in edible plants and purification and characterization of a new ribosome-inactivating protein from Cucurbita moschata. 221
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) 221
High in vitro anti-tumor efficacy of dimeric rituximab/saporin-S6 immunotoxin 220
In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells. 218
Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay 216
Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin 216
RIP activity in basic protein fractions of tissue extracts from Fragaria x ananassa 214
Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin. 214
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? 212
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity 208
Rituximab and other new anti-CD20 mAbs for non-Hodgkin’s lymphoma treatment. 202
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells 201
Potential therapeutic application of the plant toxin saporin-S6. 198
Ribosome-inactivating proteins from plants: A historical overview 198
Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. 197
Saporin-S6: a useful tool in cancer therapy. 194
Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii 193
Immunotoxins and other conjugates: pre-clinical studies. 192
Structure/funcion studies on type 1 ribosome inactivating proteins. 190
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine 190
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy 190
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase 189
The role of xanthine oxidoreductase and uric acid in metabolic syndrome 188
Sequence determination of lychnin, a type 1 ribosome-inactivating protein from Lychnis chalcedonica seeds. 187
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. 187
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents 186
Hyperuricaemia, xanthine oxidoreductase and ribosome-inactivating proteins from plants: The contributions of fiorenzo stirpe to frontline research 186
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6 185
The fundamental contribution of prof. Stirpe (and his research group) to the broadening of the scientific perspective on xanthine oxidoreductase 184
Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla. 184
The 1.4 Å Structure of Dianthin 30 Indicates a Role of Surface Potential at the Active Site of Type 1 Ribosome Inactivating Proteins 184
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia 183
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy 182
Expression of CTLA-4 in non-human primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies. 182
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties 181
Xanthine oxidoreductase: One enzyme for multiple physiological tasks 181
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms 178
Structural studies on RIPs elucidates the differences in their action on polynucleotides. 178
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling 177
Anti-tumor activity of Epratuzumab/saporin-S6. 174
Rilevazione di ricina e di altre ribosome-inactivating protein mediante un saggio di immuno-polymerase chain reaction. 173
Antibody conjugates for sarcoma therapy: How far along are we? 173
Xanthine Oxidoreductase in Drug Metabolism: Beyond A Role as a Detoxifying Enzyme 172
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction 172
Insights into penicillin-induced Chlamydia trachomatis persistence 172
Bouganin, an attractive weapon for immunotoxins 171
Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo). 170
Xanthine oxidoreductase in cancer: more than a differentiation marker 170
Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms 167
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives 166
Programmed death induced by saporin as compared to ricin in lymphoma cells. 164
Structure and Biological Properties of Ribosome-Inactivating Proteins and Lectins from Elder (Sambucus nigra L.) Leaves 162
Cell interaction of the type 1 RIP Saporin 160
Neurotossicità in vitro e in vivo delle ribosome-inactivating proteins lanceolina e stenodettilina. 159
Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells 159
Protein synthesis inhibition activity by strawberry tissue protein extracts during plant life cycle and under biotic and abiotic stresses 157
Epratuzumab/saporin-S6: a new anti-CD22 immunotoxin with a potent antitumour activity. 156
Increased serum level of xanthine oxidoreductase in liver transplanted patients. 152
Sequence, structure, and binding site analysis of kirkiin in comparison with ricin and other type 2 rips 152
Targeting CTLA-4 by its recombinant ligands CD80/CD86: Perspectives towards the development of a novel anti-tumor therapeutic approach. 152
Primi studi sull'attività Rip in fragola. 151
Two different in vitro tests confirm the blocking activity of d-galactose lectins on the adhesion of Escherichia coli F4 to pig brush border receptors 151
Morte cellulare programmataindotta dalle RIP ricina e saporina in cellule linfomatose. 150
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20 expressing cells and produces a synergistic toxic effect with Fludarabine 150
Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. 148
Research of new ribosome-inactivating proteins from adenina genus (Passifloraceae); characterization of highly toxic type 2 RIPs from Adenia lanceolata and Adenia stenodactyla. 148
mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment. 147
Toxins 145
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 144
Xanthine Oxidoreductase In Atherosclerosis Pathogenesis: Not Only Oxidative Stress. 142
Saporin induces multiple death pathways in lymphoma cells with different intensity, timing as compared to ricin. 141
Toxin and Immunotoxin Based Therapeutic Approaches 141
Ribosome‐Inactivating Proteins (RNA N‐glycosidases) from the Seeds of Saponaria ocymoides and Vaccaria pyramidata 141
Intracellular fate of saporin-S6, a putative drug for anti-cancer therapy 139
Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose 139
EVALUATION OF PLANT RIBOSOME-INACTIVATING PROTEIN TOXICITY ON INTESTINAL CELLS 137
Distribuzione dell’attività lectinica e tossica in piante appartenenti al genere Adenia (Passifloraceae) 134
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? 134
The ATG-saporin-S6 immunotoxin causes a complete depletion of activated T cells. 131
Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases 129
hLL2/saporin: un’immunotossina anti-CD22 con potente attività antitumorale. 129
Occupational sensitization to ribosome-inactivating proteins in researchers 129
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama 128
Comparative Efficacy of Ribosome-Inactivating Protein-Containing Immunotoxins in 2D and 3D Models of Sarcoma 127
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: Effect on DNA, RNA and poly(A) 123
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells 123
Gender Influence on XOR Activities and Related Pathologies: A Narrative Review 123
L’immunotossina ATG/ saporina-S6 per l’eliminazione specifica di linfociti T attivati. 120
Pro-aging effects of xanthine oxidoreductase products 117
Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin 116
Ribosome-inactivating proteins and other lectins from Adenia (Passifloraceae) 115
Toxin and Immunotoxin Based Therapeutic Approaches 112
Totale 17.483
Categoria #
all - tutte 58.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.638 0 69 107 114 131 109 27 132 87 91 424 347
2022/20232.102 253 224 103 243 150 167 63 97 445 73 202 82
2023/2024839 32 109 62 63 54 117 49 117 43 85 62 46
2024/20253.562 163 387 337 199 740 191 171 149 75 250 114 786
2025/20267.699 761 965 600 536 855 390 709 243 1.374 685 270 311
2026/2027507 291 216 0 0 0 0 0 0 0 0 0 0
Totale 21.120